Intense Drive to Check Manufacturing Units Launched Following Chhindwara Tragedy

Food and Drug Administration (FDA) has intensified its efforts to inspect drug manufacturing units operating in the state after a toxic syrup incident claimed the lives of several children in Chhindwara. The agency is also gearing up to implement instructions issued by Deputy CM and Health Minister Rajendra Shukla during a recent review meeting. A full-fledged probe is underway to identify the negligent officers responsible for the incident, and the government has warned that those found culpable will not be spared.

Key Takeaways:

• FDA has written a letter to the Association of Chemists, asking them to stop selling syrups that lack warnings about children under the age of four.
• An intense campaign is being launched to inspect drug manufacturing units operating in the state, with a focus on ensuring that vacant posts are filled and lab testing facilities are upgraded.
• Field inspections are underway to trace missing bottles of toxic Coldrif syrup, which were sold by chemists and are yet to be recovered from the buyers.
• Government investigation is focusing on identifying entry points of the syrup and the negligent officers responsible for the incident.
• Government has banned three syrups, including Coldrif, Relife, and Respifresh TR.
• Drug Inspectors are conducting inspections of medical shops in Jabalpur, the source of the toxic syrup.
• The government is looking for "black sheep" among the officers and will not spare those found guilty.

Statistics:

• At least 5 children have died in Chhindwara due to consumption of toxic syrup, according to reports.
• The FDA has issued a letter to the Association of Chemists, asking them to stop selling syrups without warnings.
• Over 100 medical shops in Jabalpur were inspected by Drug Inspectors.
• 3 syrups, including Coldrif, Reliefe,and Respifresh TR, have been banned by the government.

Sources:

• Indian National Press (Bombay) Pvt. Ltd., (2025)
• Contify.com